Bill: HB 3147, 86(R) - 2019

Committee

House Public Health

2nd Chamber Committee

Senate Health & Human Services

Vote Recommendation

Vote Recommendation Economic Freedom Property Rights Personal Responsibility Limited Government Individual Liberty
Neutral Neutral Neutral Neutral Neutral Neutral

Author(s)

Tan Parker

Co-Author(s)

Valoree Swanson

Sponsor(s)

Brandon Creighton

Bill Caption

Relating to a cancer clinical trial participation program.


Fiscal Notes

No fiscal implication to the State is anticipated.

Bill Analysis

HB 3147 would authorize an independent third-party organization to develop and implement a cancer clinical trial participation program to provide reimbursement to an individual who participates in the program for ancillary costs associated with participation in the trial. The reimbursement would be required to comply with applicable federal and state laws, and be reviewed by the institutional review board associated with the cancer clinical trial for which the reimbursement was provided.

The bill would establish that reimbursement does not constitute an inducement to participate in a cancer clinical trial, is not considered coercion or the exertion of undue influence to participate in a trial, and is meant to accomplish parity in access to cancer clinical trials and remove barriers to participation in trials for financially burdened subjects.

Vote Recommendation Notes

Texas Action remains neutral on HB 3147 because it does not affect our liberty principles.


Source URL (retrieved on 03/29/2024 08:03 AM): http://reports.texasaction.com/bill/86r/hb3147?print_view=true